急诊急性疼痛:即释硫酸吗啡联合对乙酰氨基酚与羟考酮/对乙酰氨基酚的镇痛疗效比较
这项前瞻性、随机、双盲试验纳入 80 例急诊 18 至 64 岁、11 点数字评分量表(NRS)初始评分≥5 的中度至重度急性疼痛患者,随机接受 15 mg 即释硫酸吗啡联合 650 mg 对乙酰氨基酚或 10 mg 羟考酮联合 650 mg 对乙酰氨基酚。两组基线 NRS 均分分别为 8.44 和 8.53,30、45、60 分钟疼痛评分组间差异均无统计学意义;60 分钟 NRS 较基线下降分别为 4.2(95%CI 3.43–5.01)和 3.61(95%CI 2.79–4.43)。两组均未观察到有临床意义的改变或严重不良事件,即释硫酸吗啡组药物喜好度更低。
要点
- 适用人群为急诊 18 至 64 岁、NRS 初始评分≥5 的中度至重度急性疼痛患者。
- 干预为 15 mg 即释硫酸吗啡联合 650 mg 对乙酰氨基酚,对照为 10 mg 羟考酮联合 650 mg 对乙酰氨基酚。
- 60 分钟 NRS 均分分别为 4.22 和 4.87(P=0.346),组间镇痛效果无统计学差异。
- 60 分钟 NRS 较基线下降分别为 4.2(95%CI 3.43–5.01)和 3.61(95%CI 2.79–4.43)。
- 两组恶心/呕吐发生率相似,即释硫酸吗啡组药物喜好度更低,均无严重不良事件。
适用人群与场景
- 急诊 18 至 64 岁、表现为中度至重度急性疼痛且 11 点 NRS 初始评分≥5 的患者。
诊断标准与关键阈值
- 急性疼痛程度采用 11 点数字评分量表(NRS,0=无痛,10=极重度疼痛),入组要求初始评分≥5。
处置流程与药物剂量
- 第一步:筛选急诊 18 至 64 岁、NRS 初始评分≥5 的中度至重度急性疼痛患者。
- 第二步:随机给予 15 mg 即释硫酸吗啡联合 650 mg 对乙酰氨基酚,或 10 mg 羟考酮联合 650 mg 对乙酰氨基酚(原文未提及给药途径与频次)。
- 第三步:在基线、30、45、60 分钟评估疼痛评分、药物喜好度与不良事件。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为前瞻性、随机、双盲试验,共纳入 80 例患者(每组 40 例),为单中心研究(原文摘要未明确中心数,按设计推断为单中心)。
- 两组基线 NRS 均分为 8.44 与 8.53(P=0.788),人口学特征相似(P>0.05)。
- 30 分钟 NRS 均分为 6.03 与 6.43(P=0.453),45 分钟为 5.31 与 5.48(P=0.779),60 分钟为 4.22 与 4.87(P=0.346)。
- 每组内从基线至 30、45、60 分钟的 NRS 下降均有统计学意义(各时间点 P<0.0001)。
- 60 分钟 NRS 较基线下降:即释硫酸吗啡组 4.2(95%CI 3.43–5.01),羟考酮/对乙酰氨基酚组 3.61(95%CI 2.79–4.43)。
- 两组均未观察到有临床意义的改变或严重不良事件,恶心/呕吐发生率相似,即释硫酸吗啡组药物喜好度更低。
证据类型、等级与局限
- 证据类型为前瞻性随机双盲试验。
- 局限:样本量小(80 例),随访时间短(仅至 60 分钟),原文未报告多中心设计。
对床旁实践的改变
- 在急诊 18 至 64 岁、NRS≥5 的中度至重度急性疼痛患者中,15 mg 即释硫酸吗啡联合 650 mg 对乙酰氨基酚可作为 10 mg 羟考酮联合 650 mg 对乙酰氨基酚的替代方案,60 分钟镇痛效果相似。
- 即释硫酸吗啡联合对乙酰氨基酚方案药物喜好度更低,可能有助于降低滥用倾向,但需注意该结论来自小样本单次给药研究。
- 本研究的给药途径与频次原文未提及,不能直接外推为通用推荐剂量方案。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Previous research demonstrated that administration of Morphine Sulfate Immediate Release (MSIR) results in similar analgesic efficacy to Oxycodone but with significantly lesser degrees of euphoria and reward. The purpose of this study sit to investigate if MSIR combined with Acetaminophen can serve as an opioid analgesic alternative to Oxycodone combined with acetaminophen (Percocet) for acute pain in the Emergency Department (ED).
METHODS: A prospective, randomized, double-blind trial of ED patients aged 18 to 64 years presenting with moderate to severe acute pain as defined by an 11-point numeric rating scale (NRS) with an initial score of ≥5 (0 = no pain and 10 = very severe pain). Patients were randomized to receive either 15 mg MSIR combined with 650 mg of Acetaminophen or 10 mg Oxycodone combined with 650 mg Acetaminophen. Patients were assessed at baseline, 30, 45 and 60 min. The primary outcome was reduction in pain at 60 min. Secondary outcomes include drug likeability and adverse events.
RESULTS: 80 patients were enrolled in the study (40 per group). Demographic characteristics were similar between the groups (P > 0.05). Mean NRS pain scores at baseline were 8.44 for the MSIR group and 8.53 for the Percocet group (P = 0.788). Mean pain scores decreased over time but remained similar between the groups: 30 min (6.03 vs. 6.43; P = 0.453), 45 min (5.31 vs. 5.48; P = 0.779), and 60 min (4.22 vs. 4.87; P = 0.346). Reduction in mean NRS pain scores were statistically significant from baseline to 30, 45 and 60 min within each group (P < 0.0001 at each time point for both groups). The largest NRS mean difference was from baseline to 60 min: 4.2 (95% CI: 3.43 to 5.01) for MSIR group and 3.61 (95% CI: 2.79 to 4.43) for Percocet group. No clinically significant changes or any serious adverse events were observed in either group.
CONCLUSION: MSIR provides similar analgesic efficacy as Percocet for short-term pain relief in the ED, similar rates of nausea/vomiting, and lower rates of likeability of the drug.
参考来源
- Fassassi C, Dove D, Davis A, et al. Analgesic efficacy of morphine sulfate immediate release vs. oxycodone/acetaminophen for acute pain in the emergency department. Am J Emerg Med. 2020. PMID: 33341323. doi:10.1016/j.ajem.2020.11.034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。